Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: a national cohort study using the UK Obstetric Surveillance System (UKOSS)

Covid-19 in pregnancy, View ORCID ProfileNicola Vousden, Kathryn Bunch, Edward Morris, Nigel Simpson, Christopher Gale, Patrick O’Brien, View ORCID ProfileMaria Quigley, Peter Brocklehurst, Jennifer J Kurinczuk, View ORCID ProfileMarian Knight
doi: https://doi.org/10.1101/2021.01.04.21249195
1National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, UK
Nicola Vousden
1National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, UK
2School of Population Health & Environmental Sciences, King’s College London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicola Vousden
Kathryn Bunch
1National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, UK
MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward Morris
3Royal College of Obstetricians and Gynaecologists, London, UK
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nigel Simpson
4Department of Women’s and Children’s Health, School of Medicine, University of Leeds, UK
MBChB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Gale
5Neonatal Medicine, School of Public Health, Faculty of Medicine, Imperial College London, London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick O’Brien
6Institute for Women’s Health, University College London, London, UK
MBBCh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Quigley
1National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, UK
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Quigley
Peter Brocklehurst
7Birmingham Clinical Trials Unit, Institute of Applied Health Research, University of Birmingham, UK
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer J Kurinczuk
1National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, UK
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marian Knight
1National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, UK
DPhil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marian Knight
  • For correspondence: marian.knight{at}npeu.ox.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Evidence on risk factors, incidence and impact of SARS-CoV-2 infection in pregnant mothers and their babies has rapidly expanded but there is a lack of population level data to inform accurate incidence rates and unbiased descriptions of characteristics and outcomes. The primary aim of this study was to describe the incidence, characteristics and outcomes of hospitalized pregnant women with symptomatic and asymptomatic SARS-CoV-2 in the UK compared to pregnant women without SARS-CoV-2 in order to inform future clinical guidance and management.

Methods and Findings We conducted a national, prospective cohort study of all hospitalized pregnant women with confirmed SARS-CoV-2 from 1st March 2020 to 31st August 2020 using the UK Obstetric Surveillance System (UKOSS) across all 194 hospitals in the UK with a consultant-led maternity unit. Incidence was estimated using the latest national maternity data. Overall, 1148 hospitalized women had confirmed SARS-CoV-2 in pregnancy, 63% of which were symptomatic. Therefore, the estimated incidence of hospitalization with symptomatic SARS-CoV-2 was 2.0 per 1000 maternities (95% CI 1.9-2.2) and for asymptomatic SARS-CoV-2 was 1.2 per 1000 maternities (95% CI 1.1-1.4). Compared to pregnant women without SARS-CoV-2, women hospitalized with symptomatic SARS-CoV-2 were more likely to be overweight or obese (adjusted OR 1.86, 95% CI 1.39-2.48 and aOR 2.07, 95% CI 1.53-2.29 respectively), to be of Black, Asian or Other minority ethnic group (aOR 6.24, 95% CI 3.93-9.90, aOR 4.36, 95% CI 3.19-5.95 and aOR 12.95, 95% CI 4.93-34.01 respectively), and to have a relevant medical comorbidity (aOR 1.83, 95% CI 1.32-2.54). Compared to pregnant women without SARS-CoV-2, hospitalized pregnant women with symptomatic SARS-CoV-2 were more likely to be admitted to intensive care (aOR 57.67, 95% CI 7.80-426.70) but the absolute risk of poor outcomes was low. Cesarean births and neonatal unit admission were increased regardless of symptom status (symptomatic aOR 2.60, 95% CI 1.97-3.42 and aOR 3.08, 95% CI 1.99-4.77 respectively; asymptomatic aOR 2.02, 95% CI 1.52-2.70 and aOR 1.84, 95% 1.12-3.03 respectively). Iatrogenic preterm births were more common in women with symptomatic SARS-CoV-2 (aOR 11.43, 95% CI 5.07-25.75). The risks of stillbirth or neonatal death were not significantly increased, regardless of symptom status but numbers were small. The limitations of this study include the restriction to women hospitalized with SARS-CoV-2, who may by nature of their admission have been at greater risk of adverse outcome.

Conclusions We have identified factors that increase the risk of symptomatic and asymptomatic SARS-CoV-2 in pregnancy. The increased risks of cesarean and iatrogenic preterm birth provide clear evidence of the indirect impact of SARS-CoV-2 on mothers and maternity care in high income settings. Clinicians can be reassured that the majority of women do not experience severe complications of SARS-CoV-2 in pregnancy and women with mild disease can be discharged to continue their pregnancy safely.

Competing Interest Statement

MK, MQ, PB, POB, JJK received grants from the NIHR in relation to the submitted work. KB, NV, NS and CG have no conflicts of interest to declare. EM is Trustee of RCOG, British Menopause Society and Newly Chair of the Board of Trustees Group B Strep Support.

Funding Statement

The study was funded by the National Institute for Health Research HS&DR Programme (project number 11/46/12). MK is an NIHR Senior Investigator. MK, MQ, PB, POB, JJK received grants from the NIHR in relation to the submitted work. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the HRA NRES Committee East Midlands, Nottingham 1 (Ref. Number: 12/EM/0365).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data cannot be shared publicly because of confidentiality issues and potential identifiability of sensitive data as identified within the Research Ethics Committee application/approval. Requests to access the data can be made by contacting the National Perinatal Epidemiology Unit data access committee via general{at}npeu.ox.ac.uk.

  • Non-standard abbreviations

    RCOG
    Royal College of Obstetricians and Gynaecologists
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
    Back to top
    PreviousNext
    Posted January 05, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: a national cohort study using the UK Obstetric Surveillance System (UKOSS)
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: a national cohort study using the UK Obstetric Surveillance System (UKOSS)
    Covid-19 in pregnancy, Nicola Vousden, Kathryn Bunch, Edward Morris, Nigel Simpson, Christopher Gale, Patrick O’Brien, Maria Quigley, Peter Brocklehurst, Jennifer J Kurinczuk, Marian Knight
    medRxiv 2021.01.04.21249195; doi: https://doi.org/10.1101/2021.01.04.21249195
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: a national cohort study using the UK Obstetric Surveillance System (UKOSS)
    Covid-19 in pregnancy, Nicola Vousden, Kathryn Bunch, Edward Morris, Nigel Simpson, Christopher Gale, Patrick O’Brien, Maria Quigley, Peter Brocklehurst, Jennifer J Kurinczuk, Marian Knight
    medRxiv 2021.01.04.21249195; doi: https://doi.org/10.1101/2021.01.04.21249195

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Obstetrics and Gynecology
    Subject Areas
    All Articles
    • Addiction Medicine (427)
    • Allergy and Immunology (753)
    • Anesthesia (220)
    • Cardiovascular Medicine (3284)
    • Dentistry and Oral Medicine (362)
    • Dermatology (275)
    • Emergency Medicine (478)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1166)
    • Epidemiology (13346)
    • Forensic Medicine (19)
    • Gastroenterology (898)
    • Genetic and Genomic Medicine (5137)
    • Geriatric Medicine (480)
    • Health Economics (781)
    • Health Informatics (3260)
    • Health Policy (1140)
    • Health Systems and Quality Improvement (1189)
    • Hematology (428)
    • HIV/AIDS (1015)
    • Infectious Diseases (except HIV/AIDS) (14615)
    • Intensive Care and Critical Care Medicine (910)
    • Medical Education (476)
    • Medical Ethics (126)
    • Nephrology (522)
    • Neurology (4907)
    • Nursing (262)
    • Nutrition (725)
    • Obstetrics and Gynecology (880)
    • Occupational and Environmental Health (795)
    • Oncology (2517)
    • Ophthalmology (722)
    • Orthopedics (280)
    • Otolaryngology (347)
    • Pain Medicine (323)
    • Palliative Medicine (90)
    • Pathology (540)
    • Pediatrics (1299)
    • Pharmacology and Therapeutics (548)
    • Primary Care Research (555)
    • Psychiatry and Clinical Psychology (4196)
    • Public and Global Health (7489)
    • Radiology and Imaging (1703)
    • Rehabilitation Medicine and Physical Therapy (1010)
    • Respiratory Medicine (979)
    • Rheumatology (479)
    • Sexual and Reproductive Health (495)
    • Sports Medicine (424)
    • Surgery (547)
    • Toxicology (72)
    • Transplantation (235)
    • Urology (203)